Novartis Malaysia and Institut Jantung Negara Jointly Collaborate To Tackle Atherosclerotic Cardiovascular Disease
1st ever scientific partnership in the treatment paradigm of Atherosclerotic Cardiovascular Disease (ASCVD) aiming to help patients improve the management of the disease through better care and transformative therapies